creatine has been researched along with Infarction, Middle Cerebral Artery in 9 studies
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " T2 weighted-imaging (T2WI) and 1H-magnetic resonance spectroscopy (1H-MRS) were performed, to study the changes of the imaging and the neuronal metabolites N-acetyl aspartate (NAA), creatine/phosphocreatine (Cr/PCr), choline (Cho) and lactose (Lac) in cerebrum following cerebral ischemia." | 3.72 | [The effects of Erigeron breviscapus preparation on the imaging and neuronal metabolites at the early time points after reperfusion following the ischemic cerebral injury in rats]. ( Fan, M; Li, LY; Liao, WJ; Liu, ML; Yang, WT; Yang, YH, 2003) |
| "NAA/choline (Cho) ratios were significantly reduced in both areas of T2 hyperintensity and in surrounding tissue." | 2.70 | Spectroscopic data following stroke reveal tissue abnormality beyond the region of T2-weighted hyperintensity. ( Beley, A; Brunotte, F; Demougeot, C; Giroud, M; Marie, C; Rouaud, O; Walker, P, 2002) |
| "We used a mouse model of transient middle cerebral artery occlusion." | 1.35 | In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate. ( Adriano, E; Balestrino, M; Burov, SV; Gandolfo, C; Perasso, L; Ruggeri, P, 2009) |
| "Regarding MCA infarction, contralateral tissue remote from the lesion behaves abnormally in the presence of hypertension, the NAA ratios in hypertensive patients being significantly lower." | 1.33 | Is NAA reduction in normal contralateral cerebral tissue in stroke patients dependent on underlying risk factors? ( Ben Salem, D; Brunotte, F; Giroud, M; Walker, PM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kutsuna, A | 1 |
| Aoki, J | 1 |
| Kodera, H | 1 |
| Nishiyama, Y | 1 |
| Nakane, T | 1 |
| Kimura, K | 1 |
| Abe, T | 1 |
| Niizuma, K | 1 |
| Kanoke, A | 1 |
| Saigusa, D | 1 |
| Saito, R | 1 |
| Uruno, A | 1 |
| Fujimura, M | 1 |
| Yamamoto, M | 1 |
| Tominaga, T | 1 |
| Perasso, L | 1 |
| Adriano, E | 1 |
| Ruggeri, P | 1 |
| Burov, SV | 2 |
| Gandolfo, C | 1 |
| Balestrino, M | 1 |
| Vlasov, TD | 1 |
| Chefu, SG | 1 |
| Baĭsa, AE | 1 |
| Leko, MV | 1 |
| Veselkina, OS | 1 |
| Qian, J | 1 |
| Qian, B | 1 |
| Lei, H | 1 |
| Liao, WJ | 1 |
| Yang, YH | 1 |
| Fan, M | 1 |
| Yang, WT | 1 |
| Li, LY | 1 |
| Liu, ML | 1 |
| Zhu, S | 1 |
| Li, M | 1 |
| Figueroa, BE | 1 |
| Liu, A | 1 |
| Stavrovskaya, IG | 1 |
| Pasinelli, P | 1 |
| Beal, MF | 1 |
| Brown, RH | 1 |
| Kristal, BS | 1 |
| Ferrante, RJ | 1 |
| Friedlander, RM | 1 |
| Walker, PM | 1 |
| Ben Salem, D | 1 |
| Giroud, M | 2 |
| Brunotte, F | 2 |
| Demougeot, C | 1 |
| Walker, P | 1 |
| Beley, A | 1 |
| Marie, C | 1 |
| Rouaud, O | 1 |
1 trial available for creatine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Spectroscopic data following stroke reveal tissue abnormality beyond the region of T2-weighted hyperintensity.
Topics: Aspartic Acid; Choline; Creatine; Female; Humans; Infarction, Middle Cerebral Artery; Lactic Acid; M | 2002 |
8 other studies available for creatine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Delayed white matter lesion after mechanical thrombectomy for middle cerebral artery occlusion with Libman-Sacks endocarditis].
Topics: Choline; Creatine; Endocarditis; Female; Humans; Infarction, Middle Cerebral Artery; Lactates; Middl | 2022 |
Metabolomic Analysis of Mouse Brain after a Transient Middle Cerebral Artery Occlusion by Mass Spectrometry Imaging.
Topics: Animals; Ceramides; Creatine; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Meta | 2018 |
In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate.
Topics: Animals; Brain Infarction; Brain Ischemia; Creatine; Cytoprotection; Disease Models, Animal; Infarct | 2009 |
[Amides of creatine: perspectives of neuroprotection].
Topics: Amides; Animals; Brain Ischemia; Creatine; Female; gamma-Aminobutyric Acid; Glycine; Hemodynamics; I | 2011 |
Reversible loss of N-acetylaspartate after 15-min transient middle cerebral artery occlusion in rat: a longitudinal study with in vivo proton magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Creatine; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Lo | 2013 |
[The effects of Erigeron breviscapus preparation on the imaging and neuronal metabolites at the early time points after reperfusion following the ischemic cerebral injury in rats].
Topics: Animals; Aspartic Acid; Asteraceae; Brain; Brain Ischemia; Choline; Creatine; Drugs, Chinese Herbal; | 2003 |
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice.
Topics: Adenosine Triphosphate; Administration, Oral; Animals; Apoptosis; Brain Ischemia; Caspase 3; Caspase | 2004 |
Is NAA reduction in normal contralateral cerebral tissue in stroke patients dependent on underlying risk factors?
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dominance, Cerebral; Female | 2006 |